Egypt vs Europe & Central Asia (IDA & IBRD countries): Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and

Egypt
26.0%
in 2021
Europe & Central Asia (IDA & IBRD countries)
20.8%
in 2021
Egypt rank
21st
Europe & Central Asia (IDA & IBRD countries) rank
19th

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time

  • Egypt
  • Europe & Central Asia (IDA & IBRD countries)
0102030200020102021

How they compare

Egypt currently reports 26.0% against 20.8% in Europe & Central Asia (IDA & IBRD countries), a difference of 5.2%.

That makes Egypt's figure about 1.3 times Europe & Central Asia (IDA & IBRD countries)'s.

The two have swapped places 1 time across 22 shared years of data; in 2000 it was Europe & Central Asia (IDA & IBRD countries) ahead.

Egypt ranks 21st and Europe & Central Asia (IDA & IBRD countries) ranks 19th of 185 countries.

Across the 3 decades both report, Egypt averaged higher in 2 and Europe & Central Asia (IDA & IBRD countries) in 1.

Head to head by decade

Decade Egypt Europe & Central Asia (IDA & IBRD countries) Difference Ahead
2000s 29.6% 30.6% 1.0% Europe & Central Asia (IDA & IBRD countries)
2010s 28.8% 24.1% 4.6% Egypt
2020s 26.0% 20.9% 5.1% Egypt

Averages of every year both report within each decade.

Frequently asked questions

Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Egypt or Europe & Central Asia (IDA & IBRD countries)?
Egypt, at 26.0% against 20.8% in Europe & Central Asia (IDA & IBRD countries) as of 2021.
What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Egypt and Europe & Central Asia (IDA & IBRD countries)?
5.2%, with Egypt ahead.
How many years of comparable data are there for Egypt and Europe & Central Asia (IDA & IBRD countries)?
22 years are reported by both, from 2000 to 2021.
How do Egypt and Europe & Central Asia (IDA & IBRD countries) rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
Egypt ranks 21st and Europe & Central Asia (IDA & IBRD countries) ranks 19th of 185 countries.
Where does this data come from?
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Egypt vs Europe & Central Asia (IDA & IBRD countries): Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 17 September 2026, from https://health.statizoid.com/compare/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-percent/egypt-arab-rep/europe-and-central-asia-ida-and-ibrd-countries/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-percent/egypt-arab-rep/europe-and-central-asia-ida-and-ibrd-countries/">Egypt vs Europe & Central Asia (IDA & IBRD countries): Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).